Transcatheter Edge-To-Edge Repair Is Favorable for Elderly Patients at High Surgical Risk

Mitral valve prolapse is the most frequent cause of mitral valve regurgitation and is associated to hospitalization for cardiac failure and mortality. At present, the preferred treatment for operable patients is mitral valve surgical repair.

En octogenarios de alto riesgo para cirugía la estrategia borde a borde es favorable

Transcatheter edge to edge repair (TEER) has shown great benefit patients at high surgical risk; however, it has not been well studied in the +80 population and therefore we currently have insufficient data on it. 

This analysis included 1187 patients, 872 receiving TEER (from the Mitra Swiss and Minneapolis Heart Institute Registries) and 315 presenting degenerative mitral regurgitation (DMR) caused by mitral valve prolapse, who were not operated (from the MIDAS registry).

Mean age was 82, and 44% were women.

Patients receiving TEER presented more hypertension, ischemic cardiomyopathy, atrial fibrillation, functional class III-IV, lower ejection fraction, greater left atrial and left ventricle diastolic diameters, pulmonary hypertension, and higher surgical risk. 

Read also: Is Increased Mitral Valve Gradient After MitraClip a Long-Term Prognostic Factor?

At 30 days and 6 months, mortality resulted lower for the TEER patients vs. DMR non operated patients: 3.6% vs 6.2% (odds ratio 0.55, 95% CI: 0.31–0.98; P=0.04) and 8.2% vs. 17.5% (odds ratio 0.42, 95% CI: 0.29–0.62; P <0.0001) respectively. At 4 years, survival also resulted better among the TEER patients (54% vs. 46% p <0.0001).

Because the populations were different, they were matched using Propensity Score, leaving 247 pairs of patients.

The TEER strategy presented improved 4-year survival (49% vs. 37%, P=0.002) vs DMS non operated patients. 

Read also: Impact of Edge to Edge Transcatheter Tricuspid Valve Repair.

 Procedural failure expressed by moderate/severe mitral regurgitation was associated to higher mortality at 4 years, similar that of non-operated patients. 

At multivariable analysis, mortality was associated to residual moderate/severe mitral regurgitation, age, surgical risk score, ejection fraction, atrial fibrillation, functional class, left ventricle diameter, left atrial diameter and pulmonary hypertension. 

Conclusion

In elderly patients with symptomatic degenerative mitral regurgitation and high risk for surgery, transcatheter edge-to-edge repair has been associated to better survival compared against non-surgical patients. Successfully controlling mitral valve regurgitation was key to improving survival, which should be taken into account when treating inoperable patients. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.

Reference: Giovanni Benfar, et al. European Heart Journal (2022) 43, 1626–1635.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...